The increase is being fuelled by strong consumer demand; 70% of consumers surveyed by OAG have booked flights for the future.
While travellers' willingness to fly is increasing, the Delta variant, increased COVID transmission rates and vaccination preferences weigh heavily on the near and mid-term outlook.
The large majority of consumers surveyed by OAG report being fully vaccinated. However, OAG found that only 15% of non-vaccinated individuals plan to get vaccinated before their next trip.
Many airlines and destinations are considering vaccine mandates to strengthen confidence and fight transmission. Sixty-eight % of all survey respondents said they are interested in or want domestic vaccine passports, and 70% believe vaccine passports should be required for international travel.
Alarmingly, of those that said they were not yet vaccinated, 56% said they still wouldn't get vaccinated even if the airline, airport, or destination required it to travel.
Continued COVID-19 concerns keep some travellers grounded. Of the 30% of respondents who haven't booked flights yet, 40% are waiting for vaccination rates and regulations to improve and 30% are waiting for vaccine passports to be required.
The business travel outlook remains cloudy. Only 62% of business travellers said their company is planning air travel in the next 12 months, while 38% said their company either has no plans or has not specified plans.
Holiday travel expected to bounce back. The 2021 holiday travel season projects to be a lot stronger than 2020. Of the 38% of travellers surveyed by OAG that said they typically fly for the holidays, only 40% of this group did so in 2020.
This year, the percentage of that group who do intend to fly more than doubled. Planned capacity for Thanksgiving week tells a similar story, currently with 47% more domestic seats booked than last year.
Booking behaviour remains erratic. Nearly half of travellers surveyed are still booking on short notice (between two weeks to a month in advance), and half are booking between two-six-plus months out. Eighty-eight percent expect ticket prices to rise in the next 12 months.
OAG is a global travel data provider, that has been powering the growth and innovation of the air travel ecosystem since 1929.
Headquartered in the UK, OAG has global operations in the USA, Singapore, Japan, Lithuania and China.
Sanofi increases Sanofi Ventures funding by USD625m to boost biotech and digital health investments
GC Biopharma submits IND application in South Korea for Phase 1 trial of COVID-19 vaccine candidate
AusperBio completes patient enrolment in two Phase II clinical trials of AHB-137
LakeShore Biopharma receives Nasdaq delisting determination letter
Valneva reports strong Phase 2 booster results for Lyme disease vaccine candidate VLA15
GC Biopharma files IND for Phase 3 trial of BARYCELA in Thailand
Novavax COVID-19 vaccine approved in US
WHO and UNICEF deploy PharmaJet's Tropis ID system in Afghanistan polio campaign
FDA grants priority review for GSK's gepotidacin gonorrhoea indication
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
FDA lifts pause on Valneva's chikungunya vaccine IXCHIQ for elderly, updates prescribing information
Anixa Biosciences begins US FDA approved IND transfer to support Phase 2 breast cancer vaccine trial